Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting results for a monoclonal antibody therapy in patients with advanced or recurrent lymphoma; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Small Intestine Cancer

Snippet

Sponsor: Stanford University | Conditions: Lymphoma, Small Intestine Cancer | Phase 1 | Status: COMPLETED